Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Short SellingSee which listed companies have disclosed short interest
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Transcripts

Read transcripts of webcasts and audiocasts

Transcripts

Read transcripts of webcasts and audiocasts

All regions
Finland
Sweden
Denmark
Norway
Latest
Trending
Followed

Solar Foods, Webcast, Q4'25

By Inderes2/26/2026, 10:30 AM
Solar Foods

Disclaimer: This is a machine-generated transcript and may contain inaccuracies.

Laura Sinisalo
00:01 - 00:54

Hello everyone, and welcome to Solar Foods Oyj Annual Review of 2025. My name is Laura Sinisalo, and I'm here today with Rami Jokela and Ilkka Saura. Today, we will first go through a strategy recap and then the significant events of 2025. Then we move on to financial review. And finally, we will look at what has happened after the review period. Finally, in a later stage, we have a Q&A. And as always, you have the possibility to ask questions throughout the session, which we will answer at the Q&A. But now, let's start, and I welcome Rami Jokela to the stage.

Rami Jokela
00:54 - 30:21

Thank you, Laura. So, to summarize the last year, it was a pivotal year for growth and scaling. We started our commercial journey. We actually signed the first letter of intent and Memoranda of Understanding. Actually, the volume of those is more than the designed capacity of our next factory. Factory 02. We also signed deals and delivered the first Solein to our customers. I'm very excited to see Solein being used by customers, and customers starting to do the formulation and preparation for actual launches. In some places, such as Singapore, launches have already occurred. So we had €105,000 revenues booked last year. Next, a very significant aspect is scaling. So our production capacity today is 160 tons. We started the project. The Factory 02, where we are targeting a 6.4 kilotons capacity. So the project started. I will tell more about that part of the project. Also, we announced that we are looking for strategic partners to scale globally and make a blueprint for a whole factory setup. And that is very, very good news. And we have GEA, a global leading food processing technology company from Germany, with a global presence and significant size, who is strategically partnering with us. Next, our technology is well proven. So we announced that we made a 100-fold scaling compared to laboratory. So our Factory 01 meets all the productivity targets. We achieved 1g/l per hour. And the energy efficiency is even better. What was actually targeted? Finally, regarding funding, we received grants from Business Finland totaling 10 million, for which we are very happy and thankful. And also, we completed an equity round, increasing our equity by 25 million. So, as a summary, a lot of things are happening. But perhaps the key point is still that the commercial journey has started. Let me tell a little bit more. Once more. What is our strategy and what are the highlights of 2025? So, for a strategy recap, we base our business on megatrends, and we have three major megatrends which are supporting us over many years and decades. And those are Health & Wellness, Sustainability, and a trend that is now arising a lot. Food sovereignty as well. Health and wellness. I can say what is happening in two words. Protein boom at the moment. Even more than what we expected last year. It's happening at the moment. If I just refer to some of the analysis, like Barclays research, which recently commented that 37% growth is expected by the end of the decade, any other research also indicates the same. All are indicating there is even more demand for protein than perhaps a year ago. And why is that? There's increased health and wellness focus among all consumers. Protein-enriched products are becoming mainstream across many categories, and also personalized nutrition for GLP-1 users, a group that, for example, in the US, is expected to number 30 million by the end of the decade. There's a 20% growth year on year for that. And of course, protein is a significant part of the nutrition for that. Gut health and fiber are also starting to be a significant topic for this group of people. Also health and wellness. This is one part, but another part. Health and wellness. What is happening? The big companies, such as Starbucks, Dunkin', Chipotle, and other consumer packaged goods companies. They have announced they will go for the protein. Why do they do so? They get better prices and they are selling something. What is protein-enriched? And we can see that this is perhaps also creating demand for the protein itself, particularly since the US nutrition guidelines were recently updated. Those are indicating new guidelines to double the protein intake. Daily protein intake should comprise more portions, specifying where protein should be consumed during the day. And actually, what type of protein is a very high-quality protein at every meal? What they are expecting makes us very happy as Solar Foods Oyj. They also mentioned the fermentation. Very good observation there as well because we are in a fermentation business. Gas fermentation. So, all in all, this Health and Wellness market, which is a $2 trillion market according to McKinsey, has nutrition as a big part of it. And this protein is absolutely growing a lot in that kind of segment, helping us a lot for the future. Sustainability is another big topic. The global protein supply gap needs to be addressed in a sustainable way. And we have the most sustainable protein in the world. And we are very happy with that because this is helping our momentum. And I can comment about what kind of discussions we have with the big CPG companies. They have done so. They have kept their ambitious sustainability targets, including CO2 reductions. And our discussions with these global CPG companies indicate that if they were to use our LCA (Life Cycle Assessment) – factoring in our low CO2 footprint – it could significantly change the overall CO2 footprint of their entire, huge organization, and these types of collaborations exist with major CPG companies, with examples found among our top ten partners. The last one, the food sovereignty. As I mentioned, it has been rising a lot. Actually, it was not on the radar perhaps at first, but now, because the global food system is facing huge challenges, and that is actually pressing food security. Local food production. What we have seen is that we have been contacted by many different countries around the world. Can we set up the factory in their country that they can secure the food supply, protein production locally for the need? And I believe there are many different reasons for that, one of which is geopolitical volatility. There are climate challenges, economic challenges. There's supply challenges, price challenges. Also, quality volatility. So you can see that all these are pressing that the countries also have their national agenda. They want to secure that the people in the country will get a good quality food which is also sustainably produced. And I can give one very concrete example here. Europe. The European Commission recently launched this food agri-biotech vision. And that vision states that by 2035, Europe should publicly invest €1 billion and also create 200,000 new jobs for this kind of biotech area. And also to do it so that it will be an environmentally positive protein system. This is very good. Also supporting our business very well. Gas fermentation in this document is highly appreciated. And also, allocation of the money for that kind of technologies is well listed. Actually, we are very happy with that one as well. And we are part of this dialogue with the European Union, of course. So you can see if I summarize, we have these three megatrends, perhaps different angles. They are helping us. And my main message here is to highlight the progress from where we stood one year ago to where we are today. Everything is moving even more positively to support us long-term. Let's go back to our business. We have selected our key market. The big market is the US and the Health & Performance segment, a $10 billion market that's growing, as we said, by 10%. Our category is more than 10% year on year. So very good news. On the right-hand side, you can see the challenge. What I was talking about. Demand is more than supply. And if you think about the bars, how much there is to secure Whey Protein Isolate, which is a higher standard also in the US and most needed for all these categories. What I mentioned. Now you can see there's a supply gap, and this white box on the right shows a 100 Kilotonnes gap at the moment, expected in the next two years. Even if you take all the supply additions that are globally still happening. So that means that if you think about our next factory, which is about 6.4 kilotons, we should actually have 15 factories that just take this gap. So not only one factory. This is what we talk about now. So, there is a great opportunity for Solar Foods Oyj and similar companies as well. As you can expect, when there's more demand and less supply, the prices are going up. We are actually compared to whey protein isolate and concentrate. And you can see this dot here. Our Solein price. We have publicly stated that we are targeting approximately €17 per kilo on average. But you can see what has happened since one year ago, as the Vesper price indexes for whey protein show that all prices are going up. So, in one year's time, there has been a 60% increase in whey protein isolate and concentrate prices. Isolate is on top. You can see the darker blue, and the lighter blue actually represents concentrate. So this is also good news for us. It's confirming our price point very well. What we are targeting. It seems that it's a positive signal and a development to what we are actually targeting. And that's the key news. And one of the key reasons is there is not enough supply. And that's why customers are looking for alternatives. Alternatives also for whey protein isolate and concentrate. And we are that alternative. In Solar Foods Oyj we have two major value propositions. One is Solein itself. It's excellent from a nutrition point of view. It delivers all the essential proteins. 80% protein. 10% of fibers. 6% of the healthy fats. So that's why we are compared to the whey protein isolate. And, in our opinion, also something more. Actually, keeping the fibers and beta-glucans is a big part of gut health, for example. For people who are increasingly focused on such benefits, we are a good choice. Also, we are very mild in taste, very functional, animal-free, dairy-free, gluten-free, soy-free, non-GMO. So we are free of the major allergens. And that's also very good news for many of the consumers. Sustainable. Ethical. Also, what is very key? What I say is that we are not dependent on the weather or climate conditions. This means you can scale this production anywhere. And that's why supply quality is secured, and price volatility is managed. This is not the global situation today, as I commented; furthermore, we have learned that we are superior to plant proteins. That's why we provide more value, even in comparison to whey protein isolate. And that's where they are compared. So, to put it in a nutshell, we are combining the best part of the plant proteins. And then we have the best part of animal proteins, like whey protein. And that's actually what we are as a Solein. That's one of the absolutely key value propositions that we have. And another big value proposition is our gas fermentation platform, which is how we produce Solein. You can see in the middle this box, Solar Foods Oyj, representing a technological point of view. Make a paradigm shift. We are increasing production tenfold compared to photosynthesis. Ten times. That's a paradigm shift. Food is coming out of our factory in three days time. Three days. And that's actually the key. From a technology point of view, we have something absolutely unique. To scale our intellectual property globally, we are looking for strategic partners. So you can see in the middle, for the platform, we are looking for partners for process heating, cooling, real estate, and hydrogen production. And then you can see on the left-hand side, of course, all the hydrogen, oxygen, CO2, and electricity. We are looking for the partners. Considering food companies as partners, we can access various markets, including health and performance nutrition or healthy snacking. It could be mayonnaise companies, dairy replacement formulations, egg replacement, and so on. So we start with the health and performance nutrition from the top: protein drinks, powders, bars, and so on. But of course, we have a possibility to do much, much more. If you think about the market point of view on the right-hand side, we are talking about this 10 billion market now, and then later 40 billion, then 80 billion. As you saw in the bubbles. But if you think about the ice cream market, it is around 90 billion. But the market is about 80 billion, and the mayonnaise market is 7 billion. The dairy market alone is 1 trillion, and the egg replacement market is 200 billion. So it's a huge market opportunity. That's why we are looking for partners to ensure we can scale and make a blueprint. And then we start to scale together with our partners. To make these factories more modern, we need to make many. All right, so what is our mission? In the big picture, we see that this Solein product and our platform, these two big value propositions that our company offers, are revolutionizing the global food system by providing a new way to produce food. And you can see that the most sustainable and global leading technology platform. And to make this a food ingredient for our B2B customers in the Health & Performance category, we are targeting 1 billion consumers globally. It's a big thing. So that's our target. We believe we are able to achieve this through our partnerships, not only on the customer side but also on the platform side. And also if you think of the upstream downstream point of view. And that's why we have selected three major priorities. One is the sales and product, to ensure big success in the US and with product launches. Number two, make sure that our blueprint for Factory 02 is complete, and that the production capacity can be increased. Number three, of course, we need the investment program. Actually, once we are a profitable company after Factory 02. Of course, that will make it easier. But before that, we need grants and investments and loans. All right. So, that was a recap of what we announced last year, confirming many of the topics. Like I said, the direction where the world is moving seems to very much support what we are doing as well. So value propositions are confirmed, and progress is next. So, what are the highlights? Okay. The highlights, of course, you can see I'm smiling; I'm happy to actually talk about commercial success. So we have started our journey. We have five contracts to launch Solein products in the US. We have signed MoUs for four of those. And actually, that's covering from a volume point of view, the whole design capacity of Factory 02. So, of course, now we need to convert those to firm contracts at the end. But the intentions are there. And those are global leading companies, just like you mentioned. It's not just you pick up somebody, but we are really talking with the global leading companies here. The next one, consumer products. So we are very happy with the Japanese company Ajinomoto, which is a global company. They have actually brought different kinds of products almost every month in Singapore. You have seen ice cream. You have this iced latte or you have bakery products and so on. And by the way, I have tested by myself in Singapore; those taste very, very good indeed. I'm very happy with what Ajinomoto has been doing. And this partnership has been multiple years, more than three years already. Of course, we are launching with Fermenta Pothos, and later Ilkka will come, and we have a few more contracts coming where we are launching. So, perhaps the key focus next is that, with US launches, US customers will see our Solein-based products on the markets and on shop shelves, including various product concepts. We have protein bars, protein shakes, and drinks as well. That's actually what we have been doing a lot. We have also announced that we can do mayonnaise, and much more. How, to date, does egg yolk compare to Solein in terms of functionality? From a functionality point of view, Solein is very, very good in that. But I will not go into more detail because the focus, from a regulatory point of view, is currently on health and performance. We applied for a no-question letter. In the US, we have self-GRAS, so we can do business, but we also pursue the highest level of verification in the country. And then, of course, we have been in the application process in Europe and the UK. We expect to get the approvals sometime this year. Customer collaboration is key. So, what actually is happening here? You can see some logos. We have the Ajinomoto Group. The Ajinomoto Group is actually a go-to-market partner for the flavors as well. Pothos, which is actually the Fermenta brand. So, what we are doing here is working with fast-moving health and performance nutrition companies first to get the product quickly to the market. At the same time, we are also working with significant global CPG companies, consumer packaged goods companies, and those where you can see all different kinds of food products in your retail shops every day. Very good discussions. And I am personally positively surprised that we really have access to the highest level decision-makers. And why is that? I believe it's because of the value proposition of what we have. We have a very strong value proposition. And of course, our customers have a big need, so we can help them as well. We are doing the product development via test production runs and also the consumer testing. So how does our formulation work and lock in. And then it goes to launches. Underneath, you can see the curve. These fast-moving health and performance companies typically go through all these stages. When you start concepting and positioning the product and see the market. And then you develop an application. Application development and then the manufacturing test runs in the factories. Then you proceed to commercialization, where you decide on your actions. Then you consider what kind of packaging you have, what kind of labeling you have, which market you will enter, what kind of brand you will use, and what your channel to market is. It's a very detailed process, and typically, even for a fast company like a Health & Performance company, It might take even a year if you are working with this kind of bigger global CPG company. It could be almost twice as long because, of course, it's a huge investment for those companies, and they understand that's why they really like to make sure that everything goes well. And investments, when launches happen, will, of course, create much nicer returns. We have great feedback from our B2B customers and consumers. Of course, we are collecting it, and I can say that if I summarize the feedback on how Solein has been tested and how they perceive it, nine out of ten consumers are saying, 'This is great, this is absolutely great.' And also, the story of how the food or ingredient is actually created is great as well. So we are very happy with that. In our Solein kitchen in Lappeenranta, we have had thousands of visitors. We are also doing this kind of checking. How does this Solein menu actually taste? If you have ice cream, pasta, and so on, the feedback has been very good as well. I'm very proud. We've been part of these discussions and hearing what our visitors are saying, how they see it, and typically they say that the taste texture is very good. So we always say, seeing is believing. Taste is everything. Seeing the factory, it works. Taste is everything. Actually, these Solein-based dishes and treats are very, very good. We continue our development of the Solein product. Personally, I can say that I have now been leading this company for about 11 months. So I have seen three generations of how we have been improving the ingredient to be a better fit for ready-to-mix, ready-to-drink, or protein bars. So you can see the continuous development there as well. All right, from a technology point of view. We made already this 100-fold scaling, but as you can see. On the left-hand side, from where we started, you can see the entire eight-year journey and where we are today. But personally, I'm very, very happy with what our people and technology team have been doing. They achieved all the production parameters in Factory 01. We are using that as the basis when designing Factory 02. And of course now with those parameters, given what we have achieved as a company, we can make Factory 02 already very profitable. So very good information. There's another one. Many of the visitors have been asking, are we in a batch production or continuous production? And we are in continuous production. Last year, the longest production run was eight months. So that is also one of the reasons why we can get our cost of operation so low. It's a continuous production indeed. And of course, very simple. If you think about this end to end, what is happening. Of course, the bioreactor and this kind of IP and knowledge, that's in our hands. And then of course, with our partners, we are able to do that one. I mentioned already designing Factory 02. So what we did in February, we announced the start of pre-engineering for Factory 02. And then, by August, after about half a year, we realized it was better to implement a phased investment plan. So we have three different phases. How we are going to use the money. Because then, by using the money, you already get payback and volumes. October. Actually, we announced that we implemented a strategic network of partners. Meaning, actually, the slide I showed earlier highlighted that we are looking for partners for the platform, for cooling, heating, hydrogen production, or real estate, and of course, partners for electricity procurement as well. And external partners and how this will go to market. In December, we announced that we selected Lappeenranta in Finland to be our site. It was not easy. We had a lot of criteria. So, considering what we were looking for, there were many sites within Finland and also outside. Finally, Lappeenranta was chosen. The electricity availability in the neighborhood is high; 1.5 km away, 1.5 GW of electrical power is available as well. There is a significant workforce knowledgeable in the processing industry in the neighborhood, and in Finland, there is also the Business Finland grant program, from which we expect to receive grants and support for Factory 02. These were among the many other parameters considered. We were looking for that, and that was our final conclusion. And I'm very happy actually. Cooperation with the city of Lappeenranta has been very good and smooth. So we expect this project and the factory building will develop very nicely. That's all from my side. Last comment for the year 2025 was the time I made organizational changes. I reinforced our go-to-market organization. So that we have the sales operations. We have marketing, branding, product application development, regulatory affairs, business development, and nutrition science all under one leadership. And why is that? Customers. They are looking for a complete journey. As you saw. It's not only the salespeople, but also developing the product together, going to market together, branding it together, and understanding how the nutrition science or the regulatory point of view regarding intended use actually works for our product in different countries. So it's a dialogue with the customer. It makes much, much easier and faster for our side, but also the customer happier for sure, because we can make sure that priorities are right. We also, inside the company, moved the resources to the Factory 02 project. Because we have a lot of capabilities, learnings, and expertise among our people. So how we can utilize the best way for our next factory. We also have had a lot of R&D. We funneled R&D so that it would support the product development. So, with a focus on Solein applications and products, we make sure that this R&D can be utilized for the customer benefit as soon as possible. So those are the changes. What was done. And I think Ilkka, you know the numbers very well. And you, what can you comment about that? How about if you take over now.

Ilkka Saura
30:21 - 36:04

Thank you Rami. First of all, good afternoon everyone. My name is Ilkka Saura. I'm CFO of the firm. The report is out. Financial results of FY 25. I'm very pleased to share with you some of the key highlights of the year from the financial point of view. So operating loss amounted to 10.4 million. So, somewhat material increase from last year. That's mainly because of the growth in our operations. We have recruited more people to Vantaa and internationally, we have run the factory almost throughout FY 25 at very high productivity levels. These factors mainly resulted in the increase of operating loss, and this kind of reflects the situation and the status of the company. We continue to invest in our growth. What comes to the technology itself? Commercial excellence, as well as the scaling to the industrial levels. Net debt remained at 8.9 million and net gearing at 77%. So we see an increase. Their net gearing remained at a relatively moderate level, and the equity ratio was at a very good level at year-end 2025. From the cash flow point of view, cash expenditures increased as expected, and the net cash flow for the year was 5.4 million. And we ended the year with a cash balance of 8 million. Some of the highlights from this slide I would like to mention is the order book. What we do is report the firm-committed orders of quantities and price, and through our public reporting, the order book increased from last year to 1.5 million, and that comprises two larger supply agreements with health and performance and snacking companies based in the US and EU. Regarding significant events after the period end, I can tell you what a year FY 26 has already been. So we kicked off the year with the successful private placement. So the company executed a fundraising project called Fuji by way of an accelerated book building process on 23rd of January, according to the plan that was communicated in the fall. FY 25, 55% of the allocable demand was from abroad. The round was led by our strategic partner GEA and followed by a number of institutional investors like pension funds and others. Largest shareholders, family offices, and private individuals. This indeed takes us closer to the final investment decision of F02 and allows us to execute our strategy. I want to personally thank all investors for their support and joining the round. And then another great piece of news from the field was this one. So Ambrosia Collective ordered a material amount of Solein, and that was announced earlier this year. It is a company that brings ready to mix protein powders and products designed for American sports and performance enthusiasts who demand clean nutrition, functionality, and great results. And we're more than happy to support Ambrosia on this journey and want to mention that Ambrosia is a real brand in the market. By the way, their products are being sold throughout the US through online channels, as well as the retail channels that we know their products are sold through thousands of retail stores like Vitamin Shoppe, GNC, and the like. So, it's a clear flagship logo for us and a great win. And it validates nicely our value proposition and Solein appeal to the forward looking customers in the US markets. Another significant announcement concerned the partnership with GEA. So, like we told, we are looking for and building a network of partners in the areas of utilities, power, bioprocessing and real estate, and GEA, which is a leading DAX-listed technology company in this space. With whom we have built F01 joined us through the equity issuance. And by doing that, we also agreed upon an exclusivity with Gaia to negotiate on the supply terms of the next factory. And GEA will be focusing on the bioprocess, the very core of the company. And by having these great results from F01, we believe as a company that GEA is the best partner for us on this journey. And more to come. We want to mention that we continue to negotiate with other partner candidates on long-term strategic partnerships on the utilities and real estate sides, and to end this presentation, that's the news. More to come. So with that, I hand over to Laura. Thanks.

Laura Sinisalo
36:05 - 36:31

And we are more than happy to support Ambrosia on this journey, and we want to mention that Ambrosia is an established brand in the market. So thank you very much, Ilkka and Rami. It's time for the Q&A. And there's a very nice flow of questions coming through. So I suggest we start and go ahead. So let's begin with a question regarding our commercialization. So the first question is how are you progressing with commercialization?

Rami Jokela
36:32 - 38:08

All right. Our strategy actually selects fast-moving Health & Performance companies in the US, and we have now five deals done and announced globally. Ambrosia Collective is the biggest one of those. A well-known brand. So, that's how our key part works. First part. So we select the best 5 to 8 innovative brands, we grow together. But then, at the same time, we have something that is perhaps not yet publicly able to be announced. But we are working with the huge CPG companies, and typically their process is very long. And we also like to make sure that from our Factory 01's volume, we have something left for them for testing and limited launches and test marketing as well. But what I'd like to say, what I'm very positively surprised by, coming from huge companies myself in the past, is that we have access to these big CPG companies' decision-makers, and one more time, why is that? I have been wondering and discussing with Ilkka why our value proposition and Solein are very good. Demand is high, and there's not enough good whey protein available. So we know that the time is now. And so commercialization is continuing. There's more to see this year. This will be a very exciting year. It is my opinion that if things go very well. So then we have something great to announce.

Laura Sinisalo
38:09 - 38:17

Thank you, Rami. I would continue with a question regarding whey because you mentioned it. So why do you compare Solein to whey protein?

Rami Jokela
38:18 - 39:44

If you compare plant proteins and whey protein, you have two different types of whey. You have whey protein isolate, which actually doesn't have lactose, and which doesn't have these kinds of saturated fats. Those are filtered away. Whey protein concentrate 80 still has lactose. They also contain saturated fats, which are not very good. Perhaps some of the people who are selecting their dietary protein consider these factors. So if you think about Solein, our protein content is 80%. It's more than many of those plant proteins. And amino acid profile is equal or similar. Its profile is comparable to that of whey protein. If you think about the pdcaas, how well your human body can digest this protein. We have to say that the theoretical score is one. It's the same. It is like whey protein. If you go to plant proteins, then it's always less. And plant products might also have other challenges, such as taste and texture. So, whey protein taste and texture is always very good. So it's easy to compare. That's why we are seeing. And by the way, some of the big companies, when they have been testing, they have been commenting to us that they compare us to whey protein as such. So we are very happy with that because you can see the price of whey was developing, going up, and supply gaps, we can help.

Laura Sinisalo
39:46 - 39:59

One more regarding commercialization. You touched upon this already, but there's a question regarding. Offtakes. So when will there be offtakes from major food brands?

Rami Jokela
40:00 - 41:06

Offtakes typically come from bigger brands. So, these fast-moving Health & Performance companies are growing, of course, and we are increasing volume together with them. But then the bigger offtakes will come with these big Health & Performance companies, or the CPG companies. We are in the process. We are in the application development process for their formulation and testing of Solein. So, actually, this kind of sequences, first they need to think what is the value proposition. How the product Solein will be positioned as an ingredient. Next involves product application formulation and, later, even manufacturing testing to see how it works. And then we'll come to all the launch plans, commercialization plans. And this could take actually two years. So I would love to have it faster. But it's a process. It's what these kinds of food companies, especially big food companies, like to go through. And we are in a journey together with them, many of them at the moment.

Laura Sinisalo
41:06 - 41:15

Thank you Rami. Then there's a question, what are the major upcoming steps to receive the sales permit for Solein in Europe and in UK?

Rami Jokela
41:16 - 42:11

Okay, perhaps I will take this as well. So in Europe, we have been in the process for four and a half years already. It's a very long process. We see that we are now at the end of the process. There should not be too many questions anymore. We have announced that earlier this year we expect to get all the approvals as well. So we are hopeful it will happen. It will happen this way. It will be a five year process, more or less or even more. And now, the UK seems to be a little bit faster. You can change the legislation so that there's no need to go to Parliament for final approval. So once the authorities have approved, then it's possible to already go to the market. So it might be even half a year faster in that sense. And that's why we expect both to happen this year.

Laura Sinisalo
42:11 - 42:24

Then you said you are negotiating with GEA about a partnership. Then perhaps, the order book remained unchanged in H1 and H2. Why were no new orders secured during H2?

Unknown 1
42:25 - 42:27

I can briefly answer, Ilkka.

Ilkka Saura
42:27 - 43:25

Please feel free to comment also. So the order book remained flat. In the H2 financial report, the order book remained at 1.5 million. In the H2 report, the order book remained at 1.5 million. However, these orders that we have announced and the increase in revenue signal that there has been a lot more, and we expect to have more of those. There are two kinds of contracts. There are shorter contracts, and there are longer contracts. These long-term contracts are for committed quantities, and prices are recorded and recognized in the order book, whereas short-term, quarterly deliveries and orders are typically delivered, billed, and collected within the six-month review period. So. So that's why those are not in the order book.

Laura Sinisalo
43:26 - 43:27

Then you said you are negotiating with GEA about a partnership.

Rami Jokela
43:28 - 44:05

To add, we also want to secure the available volume for these big CPG companies. So, purposely, we are a little bit selective, as we don't want to, at this moment, have a big order book with smaller companies for many years, because we might not have the volume to conduct all these kinds of tests and limited launches with the bigger companies, given that bigger companies will lead to Offtakes. So, we are really using Factory 01, our demo factory, to pave the way for major off-take agreements and the ramp-up of Factory 02.

Laura Sinisalo
44:07 - 44:19

Then perhaps, the firm order backlog remained unchanged in H1 and H2. Then you said you are negotiating with GEA about a partnership. What does this mean for Solar Foods Oyj?

Rami Jokela
44:20 - 45:31

Okay, I can comment. GEA is a global leading food processing company. They also have been investing a lot in the food tech. On the deck, you can see GEA. Actually, at all these global food tech events, they are very visible. So, as Solar Foods Oyj, I think we should be very happy that they actually selected us, because I think they know all different kinds of platforms and companies. And I believe that they also, as Ilkka was commenting, have been working with us on Factory 01 for three years. So all the downstream processing part is coming from GEA. So we know how it works as well. So this is not just a test, but we have tested it already many years. So it's a very good confirmation for this. Our gas fermentation platform, where we have received very good comments. Also good for VTT Research and other places. And this is the leading platform. We see ourselves as one of the leading companies in this whole area. Now, actually, it is about supporting global scaling. It's very good.

Laura Sinisalo
45:31 - 45:45

Indeed, you can see GEA. Rami. Let's continue this topic a little bit because there's a question. You say you are looking for collaboration based primarily on heating, cooling and hydrogen provision. Are no license royalty scenarios possible?

Ilkka Saura
45:47 - 46:15

Currently, we continue to work with the existing strategy on entering the health and performance markets in the US by selling the ingredients through B2B business model. Licensing remains as a long term target beyond the existing strategy period. But of course, it's continuously being evaluated. Currently, the most lucrative way to continue is to pursue this particular strategy.

Laura Sinisalo
46:17 - 46:34

GEA is a global leading food processing company. Ilka. Then, there's a question going into 26: does Solar Foods Oyj prioritize finding new large industrial scale clients for Factory 02 or smaller, fast-moving players that could come to market with Solein products faster?

Rami Jokela
46:35 - 47:31

Great question again. Perhaps I will take it. Key for us in our strategy is to get Solein ingredient products to market quickly. That's why we have selected these fast health and performance nutrition companies. And you can see that in less than a year, our launches are already happening. This is actually the case, even if you consult any consultants. They are saying, wow, this is actually faster than they expected. For bigger companies, it takes time. So that's why you can see we have two focus areas: to get products quickly to market and to grow with innovative brands, Ambrosia Collective being a good example. But at the same time, we also work on this kind of long journey to secure large volumes. And those are typically the big multibillion CPG companies, but it takes up to two years for everything to be done. Perhaps I will take it. And then you have everything, actually. And we are well in the process.

Laura Sinisalo
47:32 - 47:48

Thank you. Rami. Let's take a last question. And this is to you, Rami. Actually, Rami, what are the main changes you have aimed to implement at Solar Foods Oyj during your time as a CEO? What have been the main surprises you have run into?

Rami Jokela
47:49 - 47:49

Wow.

Laura Sinisalo
47:49 - 47:50

That's that.

Unknown 1
47:52 - 47:53

Personal reflections.

Rami Jokela
47:55 - 49:43

I have to say that, Solar Foods Oyj. I knew that when I, of course, was chosen by the board of Solar Foods Oyj as CEO. But also, I was looking at that time, I have to say that, I was looking for something that always had supporting megatrends, big markets, and a good value proposition. And then who are the ecosystem partners and stakeholders around and other people, experts around. All of that confirmed to me the spirit to excel. Let's do it. It's all there. And a value proposition. Very good. Both for Solein as well. Actually, this gas fermentation as a platform, so I don't know if it's a confirmation. It's not a surprise. The big surprise actually has been that we have had access to these multi-billion companies and their highest-level decision-makers, and that we have been welcomed, and our people have been able to go there. Why is that? There's so much demand, and we have a solution, and our value proposition works. And perhaps that has been the surprise for me, that typically, gaining access to these dialogues and all this would take time. And then you need to do something. So here we have had, I don't know if it's by luck, but at least I think our product works. Our product is so good. And then, actually, when they're testing it, the dialogue starts. So this is perhaps a positive surprise. And then of course, it's an absolutely positive surprise, like GEA becoming our strategic partner and actually investing in Solar Foods Oyj as well. Confirmation of our platform and our other dialogues that we have in the pipeline with other partners as well. So I'm very pleased with that. And looking forward to what we might announce next.

Laura Sinisalo
49:44 - 49:47

Thank you Rami. Any last words before we close this up?

Rami Jokela
49:48 - 50:13

Ilkka Saura. Should we? Actually, this gas fermentation as a platform, I'm not sure if it's a confirmation. Let's thank all our customers, both existing and future, and partner with strategic partners, as we've mentioned a few of those. And I'm very thankful for all the great work that our professionals in the Solar Foods Oyj have been doing the last year. And I'm very excited for this year. So we have great opportunities ahead of us. Let's make it happen.

Ilkka Saura
50:14 - 50:14

And then of course, it's absolutely a positive surprise, like GEA becoming our strategic partner and investing in Solar Foods Oyj as well.

Laura Sinisalo
50:14 - 50:19

Thank you very much for joining us today and have a good rest of the day.

Continue to the webcast
Revenio Group Oyj, Q3'26
Language: English11/12/2026, 1:00 PM
Jukka Kainulainen Good afternoon, and welcome to the Revenio Group Corporation Q3 Earnings Call. My name is Jouni Toijala. I am the CEO. And then, again today we have Jukka Kainulainen, our CFO, on th…
Kamux, Q3'26
Language: English11/12/2026, 9:00 AM
Katerina Heterant Good morning. Welcome to the Kamux Q3 results presentation. My name is Katerina Heterant and I am Head of Investor Relations at Kamux. Today we shall go through the Q3 results presen…
Koskisen, Webcast, Q3'26
Language: Finnish11/12/2026, 8:00 AM
Jukka Pahta Hyvää huomenta ja tervetuloa tähän osavuosikatsaustilaisuuteen! Koskisen tammi–syyskuun osavuosikatsaustilaisuuteen lähdetään otsikolla: Koskisen liikevaihdon kasvu jatkui. Kohonneet kusta…
Reaktor, Q3'26
Language: Finnish11/11/2026, 9:00 AM
Pekka Horo Oikein hyvää aamupäivää kaikille ja tervetuloa tähän meidän webcastiimme. Olen Pekka Horo, Reaktorin toimitusjohtaja, ja kanssani täällä on tänään Antti Akkanen, joka aloitti lokakuussa Rea…
Savox, Q3'26
Language: English11/10/2026, 11:00 AM
Paulina Tanila Our speakers today are CEO Jerry Kettunen and CFO Juha Järvi. Jerry will give an overview of Savox as a company and go through the highlights of the quarter. After that, Juha will conti…
Raisio Oyj, Webcast, Q3'26
Language: Finnish11/10/2026, 10:00 AM
Elli Siltala Hyvää marraskuista päivää Raisiosta! Ja tervetuloa Raision tammi-syyskuun 2026 osavuosikatsauksen webcastiin! Pahoittelut pienistä teknisistä haasteista, mitä meillä oli tässä alussa. Min…
Mandatum Oyj, Audiocast, Q3'26
Language: English11/10/2026, 9:00 AM
Lotta Borgström Good morning, everyone, and welcome to the Mandatum Q3 2026 audiocast. My name is Lotta Borgström from Investor Relations. Joining me today are our CEO, Petri Niemisvirta, and our CFO,…
Solar foods Go-to-market Update
Language: English11/9/2026, 12:00 PM
Maria Hello everyone, and welcome to the Solar Foods go-to-market update. My name is Maria and I'm here today with our CEO, Rami Jokela, and CFO and Deputy CEO, Ilkka Saura. Also with us today is Heli…
Outokumpu, Webcast, Q3'26
Language: English11/6/2026, 12:30 PM
Johan Welcome to the third quarter results webcast. I am responsible for investor relations. We will start with the presentation from our CEO, Kati ter Horst, and our CFO, Marc-Simon Schaar. After the…
Endomines, Webcast, Q3'26
Language: English11/5/2026, 1:00 PM
Andy Turpin Hello, everyone, and welcome to Endomines' third-quarter results webcast. Thanks for joining us today. My name is Andy Turpin and I am the Chief Communications Officer here at Endomines. A…
Lemonsoft Oyj, Q3'26 webcast
Language: English11/5/2026, 11:00 AM
Unknown 1 Welcome to the Lemonsoft Q3 results presentation. We will start with the presentation from CEO Alpo Luostarinen, followed by the Q&A. You can send your questions throughout the event via the…
Enersense, Webcast, Q3'26
Language: English11/5/2026, 10:30 AM
Liisa Tamminen Hello and welcome to the Enersense Q3 2026 results webcast. My name is Liisa Tamminen from Enersense Investor Relations. And with me here I have our CEO, Kari Sundbäck, and CFO, Jan-Elo…
Sitowise, Q3'26
Language: English11/5/2026, 10:00 AM
Mari Reponen Good day everyone, and welcome to the Sitowise Q3 2026 results audiocast. My name is Mari Reponen, and I am responsible for strategy and IR here at Sitowise. And today with me are our act…
Orthex, Webcast, Q3'26
Language: English11/5/2026, 9:00 AM
Alexander Rosenlew Good morning and welcome to the Orthex Interim Report. My name is Alexander Rosenlew and with me I have Saara Mäkelä, CFO, and Hanna Kukkonen, our CMSO. We will take you through the…
Suominen Oyj, Q3'26
Language: English11/5/2026, 8:30 AM
Anni Luoma Good morning, everyone, and welcome to the Suominen Q3 webcast. My name is Anni Luoma. I am the Manager of External Communications and Investor Relations at Suominen. Here with me are our P…
Lumo, Webcast, Q3'26
Language: English11/5/2026, 8:00 AM
Niina Saarto Good morning, all. Welcome. This is Lumo Homes plc's third quarter result webcast. I am Niina Saarto from Treasury and Investor Relations. Today I have two gentlemen here with me, namely…
CapMan, Webcast, Q3'26
Language: English11/5/2026, 7:30 AM
Charlotte Good morning and welcome to this presentation of CapMan. Q3 2026 interim report. Presenting today we have Pia Kåll, CEO of CapMan. And after the presentation, we will have a Q&A session. You…
Marimekko, Webcast, Q3'26
Language: English11/4/2026, 12:00 PM
Anna Good afternoon. My name is Anna and I am the IRO of Marimekko. It is my pleasure to welcome you to our Q3 webcast. With me, I have our president and CEO, Tiina Alahuhta, who will walk you through…
Administer, Webcast, Q3'26
Language: Finnish11/4/2026, 9:00 AM
Kimmo Herranen Welcome to the Administer Q3 2026 interim report. Results. Meillä on se alkaa. I am Kimmo Herranen. Kalle Lehtonen. Also. Kaarina og. Yelken. Kalle Lehtonen En el coco. Madan. Parannus.…
Kempower, Webcast, Q3'26
Language: English11/4/2026, 8:30 AM
Unknown 1 Powering the planet. Kempower. We charge our planet for the better. By powering the electric movement. We enable quick and scalable EV charging solutions for everyone and everywhere. We ma…